Strain→ | H-2 Haplotypes | Cytokines (pg/ml) | |
---|---|---|---|
Formulation↓ | BALB/c (H-2d) | CBA/J (H-2k) |  |
V3-gp41 Peptide | 623 ± 53 | 504 ± 29 | IFN-γ |
 | 440 ± 19 | 291 ± 38 | IL-2 |
 | 41 ± 8 | 35 ± 4 | IL-4 |
V3-gp41 in Liposomes | 1100 ± 101 | 992 ± 63 | IFN-γ |
 | 487 ± 21 | 321 ± 28 | IL-2 |
 | 70 ± 14 | 30 ± 2 | IL-4 |
V3-gp41 in ISCOMs | 1543 ± 165 | 1312 ± 287 | IFN-γ |
 | 511 ± 28 | 360 ± 14 | IL-2 |
 | 60 ± 20 | 42 ± 9 | IL-4 |
V3-gp41: MA729 in Liposomes | 1210 ± 84 | 1413 ± 152 | IFN-γ |
 | 489 ± 31 | 392 ± 30 | IL-2 |
 | 58 ± 2 | 58 ± 6 | IL-4 |
gp41 Peptide | 589 ± 54 | 623 ± 82 | IFN-γ |
 | 401 ± 16 | 368 ± 41 | IL-2 |
 | 62 ± 11 | 48 ± 21 | IL-4 |
gp41 Peptide in Liposomes | 891 ± 16 | 924 ± 72 | IFN-γ |
 | 519 ± 2 | 400 ± 21 | IL-2 |
 | 18 ± 54 | 32 ± 11 | IL-4 |
gp41 Peptide in ISCOMs | 937 ± 20 | 1321 ± 91 | IFN-γ |
 | 521 ± 9 | 500 ± 48 | IL-2 |
 | 61 ± 156 | 51 ± 4 | IL-4 |
gp41 : MA729 in Liposomes | 1230 ± 19 | 1601 ± 134 | IFN-γ |
 | 620 ± 10 | 635 ± 178 | IL-2 |
 | 20 ± 71 | 40 ± 2 | IL-4 |
p17 Peptide | 453 ± 31 | 368 ± 28 | IFN-γ |
 | 301 ± 31 | 371 ± 18 | IL-2 |
 | 16 ± 3 | 20 ± 4 | IL-4 |
p17 Peptide in Liposomes | 1211 ± 96 | 892 ± 44 | IFN-γ |
 | 520 ± 25 | 421 ± 28 | IL-2 |
 | 65 ± 9 | 30 ± 5 | IL-4 |
p17 Peptide in ISCOMs | 1135 ± 157 | 1031 ± 45 | IFN-γ |
 | 520 ± 25 | 423 ± 21 | IL-2 |
 | 45 ± 5 | 31 ± 8 | IL-4 |
p17 : MA729 in Liposomes | 933 ± 28 | 1214 ± 76 | IFN-γ |
 | 581 ± 34 | 408 ± 16 | IL-2 |
 | 53 ± 8 | 55 ± 7 | IL-4 |
p24 Peptide | 411 ± 40 | 284 ± 33 | IFN-γ |
 | 387 ± 22 | 258 ± 19 | IL-2 |
 | 48 ± 7 | 54 ± 9 | IL-4 |
p24 Peptide in Liposomes | 989 ± 107 | 1123 ± 49 | IFN-γ |
 | 460 ± 42 | 270 ± 29 | IL-2 |
 | 55 ± 6 | 34 ± 9 | IL-4 |
p24 Peptide in ISCOMs | 1007 ± 129 | 1290 ± 121 | IFN-γ |
 | 508 ± 16 | 689 ± 43 | IL-2 |
 | 49 ± 8 | 36 ± 2 | IL-4 |
p24 : MA729 in Liposomes | 1241 ± 68 | 1334 ± 59 | IFN-γ |
 | 500 ± 24 | 621 ± 26 | IL-2 |
 | 52 ± 7 | 41 ± 4 | IL-4 |